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Cardellina and coworkers possess interesting anticancer 
properties.2 In addition, 5,6-dihydro-2H-pyran-2-ones 
as chemical intermediates have widely been applied to 
the synthesis of numerous organic compounds including 
heterocycles.8 Nowadays, there are several synthetic routes 
to the preparation of these heterocycles including 
intramolecular cyclization, N-heterocyclic carbene-
precatalyst (NHC-precatalyst) reaction of enals and 
ketones, dicobaltoctacarbonyl-mediated tandem (5+1)/(4+2) 
cycloaddition, ring-closing metathesis of dienes containing 
carboxylate group by Grubbs II catalyst, (3+2) cyclo-
addition reaction, condensation reaction, and biosynthesis 
pathway. 
5,6-Dihydro-2H-pyran-2-ones constitute an 
important class of heterocyclic compounds which 
also may be considered as α,β-unsaturated 
δ-lactones. These types of heterocycles have 
shown a wide range of biological and pharmacological 
activities including human antitumor,1,2 antifungal,3,5 
antimicrobial,4 anti-inflammatory,4 antistress,4 antibiotic,5 
antituberculosis,6 antiparasitic,6 antiviral;7 5,6-dihydro-2H-
pyran-2-ones are also known as the inducer of a colony 
stimulating factor in bone marrow stromal cells.5 All this 
made 5,6-dihydro-2H-pyran-2-ones more attractive both 
for chemists and pharmacologists. For example, 
(R)-rugulactone which was firstly reported in 2009 by 
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Intramolecular cyclization 
(+)-Dodoneine (2) is a 5,6-dihydro-2H-pyran-2-one natural 
product which has been recently isolated from Tapinanthus 
dodoneifolius that grows in Burkina Faso (West Africa).9 This 
heterocycle among other biological activities exhibits vaso-
relaxant effect on preconstricted rat aortic rings.10 Very 
recently an efficient route to total synthesis of this heterocycle 
has been reported where in the final step Z-configured 
α,β-unsaturated ester 1 in the presence of AcOH via phenol 
deprotection, ketal removal, and intramolecular cyclization 
gives pure (+)-dodoneine (2) in 68% yield.11 
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Recently, novel spirocyclic oxindole-5,6-dihydro-2H-pyran-
2-ones 5 have been enantioselectively prepared by the use 
of catalytic amounts of La(OTf)3 and N-heterocyclic 
carbene (6) as precatalyst through the (4+2) annulation 
between α-bromoenals 3 and isatins 4.12 
Also, in other recently reported route, 5,6-dihydro-2H-
pyran-2-ones 9 have been enantioselectively synthesized 
through an oxidative γ-addition of enals 7 to trifluoroaceto-
phenones 8 by Mg(OTf)2/Sc(OTf)3 and N-heterocyclic 
carbene 10 cooperative catalysis in the presence of an 
external oxidant 11.13  
NHC-precatalyst reaction of enals and ketones 
In a newly introduced route to 5,6-dihydro-2H-pyran-
2-ones, dicobaltoctacarbonyl complex [Co2(CO)8] ensures 
an intramolecular carbonylation of cis-epoxyalkynes 12 to 
generate Co2(CO)6-stabilized γ-lactonyl allenes which 
under heating in benzene are transformed into 5,6-dihydro-
2H-pyran-2-ones 13. This transformation can be described 
as a tandem (5+1)/(4+2) cycloaddition between epoxy-
alkyne, CO, and diene functionalities.14 
Dicobaltoctacarbonyl-mediated tandem (5+1)/(4+2) cycloaddition 
Novel type of 5,6-dihydro-2H-pyran-2-ones 18 have been 
synthesized via (3+2) cycloaddition reaction between 
azomethine ylide 17 with electron-deficient 4-aryl-
6-(trifluoromethyl)-2-pyrones 16. It should be mentioned 
that azomethine ylide 17 is in situ generated from sarcosine 
and formaldehyde.16 
(3+2) Cycloaddition reaction 
Synthesis of (–)-spicigerolide 15, a natural product which 
has been isolated from Hyptic spicigera and has been used 
in the treatment of gastrointestinal disturbances, skin 
infections, wounds, and insect bites, is recently reported via 
ring-closing metathesis of acrylate 14 effected by the 
second generation Grubbs ruthenium catalyst to obtain 
5,6-dihydro-2H-pyran-2-one 15.15 
Ring-closing metathesis of dienes containing carboxylate group by Grubbs II catalyst 
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5,6-Dihydro-2H-pyran-2-one scaffold is found also in 
withanolides, a group of natural products which have 
shown a variety of biological activities.18 Gupta and 
coworkers reported biosynthesis of withanolide A (25) 
using farnesyl diphosphate synthase (FPPS) and squalene 
synthase (SQS). The key steps in this procedure is FPPS- 
and SQS-catalyzed transformation of isopentyl diphosphate 
to farnesyl diphosphate and farnesyl diphosphate to 
squalene, respectively.19a,b 5,6-Dihydro-2H-pyran-2-one 24 
is formed from reaction of next generated aldehyde 22 with 
2,3-dimethylbut-2-enoate 23 and LiHMDS in a mixture of 
THF and DMPU via an aldol condensation reaction. 
Finally, withanolide A (25) is obtained from compound 24 
through further multiple steps.19c 
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Condensation reaction 
In another recent attempt, a novel route to synthesis of 
5,6-dihydro-2H-pyran-2-ones 20 was described by Shimizu 
and coworkers. In this newly reported condensation 
reaction, 3-amino-2-pyrones 20, 21 are obtained via a 
highly regioselective tandem N-alkylation/vinylogous aldol 
reaction of β,γ-alkenyl-α-iminoesters 19 under given 
conditions.17 
Biosynthesis 
